Traneta® is a preparation of Linagliptin 5 mg tablet, used for the treatment of Type-2 diabetes. It is a unique DPP-4 inhibitor which acts non-renal excretion pathway. As a result no dose adjustment is required and no regular kidney screening is required for dose adjustment decision.
Traneta Tablet 5 mg
The recommended dose of Linagliptin is 5 mg once daily and can be taken with or without food. If added with Metformin, the dose of Metformin should be maintained and Linagliptin administered concomitantly. When used in combination with Sulfonylurea, a lower dose of Sulfonylurea may be considered to reduce the risk of hypoglycemia.